Market Overview:
The global biodegradable stents market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD), technological advancements in bioabsorbable stents, and rising demand for minimally invasive procedures. However, the high cost of biodegradable stents may restrain the growth of this market during the forecast period. Based on type, the global biodegradable stents market is segmented into polymer-based bioabsorbable stents and metal-based bioabsorbable stents. The polymer-based bioabsorbable segment is expected to grow at a higher CAGR than the metal-based bioabsorbable segment during the forecast period owing to its advantages such as easy manufacturing process, low toxicity, and degradation rate that matches with natural tissue remodeling process. Based on application,the global biodegradable Stent Market is divided into coronary artery disease (CAD) and peripheral artery disease (PAD). The CAD segment accounted for a larger share of this market in 2017 owing to factors such as increasing incidence rates of CAD across all regions worldwide and growing preference for minimally invasive procedures over traditional open heart surgeries.
Product Definition:
A biodegradable stent is a type of medical device that is used to keep open an artery or other blood vessel. A biodegradable stent is made out of a material that breaks down over time, which allows the stent to be absorbed by the body.
Polymer Based Bioabsorbable Stents:
Polymer-based bioabsorbable stents are made from polymers and have the ability to degrade or biodegrade in a predictable manner. They are used as scaffolds that support cells and promote their growth, while being able to be removed by the body’s natural processes after a period of time.
Metal Based Bioabsorbable Stents:
Metal-based bioabsorbable stents are used in biodegradable stents. The metal based bioabsorbable stent is made of a polymer core covered with thin layer of titanium dioxide. This coating allows the metal to react with the medication and thus, release it over a period of time as determined by the physician.
Application Insights:
The coronary artery disease segment dominated the global market in terms of revenue share in 2017. Growing awareness about the benefits associated with the usage of biodegradable stents such as reduced risk of blood clots, reduced pain and suffering, faster healing process is expected to boost demand for biodegradable stents over the forecast period.
In addition, factors including high cost associated with conventional metal based coronary artery intervention devices are anticipated to augment demand for bioabsorbable polymer based coronary artery disease treatment devices thereby driving growth over the forecast period. Coronary Artery Disease (CAD) is one of the most common diseases affecting humans globally due to increasing life expectancy and rising prevalence rates.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing cases of coronary artery disease, technological advancements, and high adoption of advanced medical devices. Moreover, growing preference for minimally invasive surgeries is also expected to drive regional growth over the forecast period. Europe accounted for a significant share in terms of revenue as well as volume in 2017 owing to high demand for biodegradable stents from countries such as Germany and U.K., which are among the top 10 markets globally with respect to GDP (Gross Domestic Product).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Rising geriatric population
- Growing demand for minimally invasive surgeries
- Technological advancements in stent manufacturing process
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Biodegradable Stents Market Research Report
By Type
Polymer Based Bioabsorbable Stents, Metal Based Bioabsorbable Stents
By Application
Coronary Artery Disease, Peripheral Artery Disease
By Companies
Abbott Laboratories, Kyoto Medical Planning, Reva Medical, Elixir Medical Corporation, Amaranth Medical, Terumo Corporation, Arterius Limited, Biotronik, Xenogenics Corporation, Meril Life Sciences Pvt
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Biodegradable Stents Market Report Segments:
The global Biodegradable Stents market is segmented on the basis of:
Types
Polymer Based Bioabsorbable Stents, Metal Based Bioabsorbable Stents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coronary Artery Disease, Peripheral Artery Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Kyoto Medical Planning
- Reva Medical
- Elixir Medical Corporation
- Amaranth Medical
- Terumo Corporation
- Arterius Limited
- Biotronik, Xenogenics Corporation
- Meril Life Sciences Pvt
Highlights of The Biodegradable Stents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymer Based Bioabsorbable Stents
- Metal Based Bioabsorbable Stents
- By Application:
- Coronary Artery Disease
- Peripheral Artery Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biodegradable Stents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biodegradable stents are medical devices that are made from biodegradable materials. These stents can be used to treat coronary artery disease, and they dissolve over time in the body.
Some of the major companies in the biodegradable stents market are Abbott Laboratories, Kyoto Medical Planning, Reva Medical, Elixir Medical Corporation, Amaranth Medical, Terumo Corporation, Arterius Limited, Biotronik, Xenogenics Corporation, Meril Life Sciences Pvt.
The biodegradable stents market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biodegradable Stents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biodegradable Stents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biodegradable Stents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biodegradable Stents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biodegradable Stents Market Size & Forecast, 2020-2028
4.5.1 Biodegradable Stents Market Size and Y-o-Y Growth
4.5.2 Biodegradable Stents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polymer Based Bioabsorbable Stents
5.2.2 Metal Based Bioabsorbable Stents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Coronary Artery Disease
6.2.2 Peripheral Artery Disease
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biodegradable Stents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biodegradable Stents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polymer Based Bioabsorbable Stents
9.6.2 Metal Based Bioabsorbable Stents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Coronary Artery Disease
9.10.2 Peripheral Artery Disease
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polymer Based Bioabsorbable Stents
10.6.2 Metal Based Bioabsorbable Stents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Coronary Artery Disease
10.10.2 Peripheral Artery Disease
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polymer Based Bioabsorbable Stents
11.6.2 Metal Based Bioabsorbable Stents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Coronary Artery Disease
11.10.2 Peripheral Artery Disease
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polymer Based Bioabsorbable Stents
12.6.2 Metal Based Bioabsorbable Stents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Coronary Artery Disease
12.10.2 Peripheral Artery Disease
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polymer Based Bioabsorbable Stents
13.6.2 Metal Based Bioabsorbable Stents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Coronary Artery Disease
13.10.2 Peripheral Artery Disease
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biodegradable Stents Market: Competitive Dashboard
14.2 Global Biodegradable Stents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Kyoto Medical Planning
14.3.3 Reva Medical
14.3.4 Elixir Medical Corporation
14.3.5 Amaranth Medical
14.3.6 Terumo Corporation
14.3.7 Arterius Limited
14.3.8 Biotronik, Xenogenics Corporation
14.3.9 Meril Life Sciences Pvt
